Climb Bio, a clinical-stage biotech company focusing on immune-mediated diseases, announced that its executive team will participate in two upcoming investor conferences: the H.C. Wainwright BioConnect Investor Conference on May 19 and the Jefferies Global Healthcare Conference on June 4. These events will feature fireside chats and live webcasts accessible via Climb Bio's website, with replays available for at least 30 days. The company is advancing its pipeline, including budoprutug, an anti-CD19 antibody, and CLYM116, targeting IgA nephropathy, highlighting ongoing clinical development progress.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
DMG Blockchain Solutions announced two strategic investments: one in MeetAmi Innovations, a Canadian fintech offering digital asset wealth management platforms, and another in Atomic47 Labs, an AI company focused on secure, sovereign AI infrastructur...
Gnosis (GNO) surged 13% in 24 hours, closing in on overtaking BONK by market capitalization to reach the 100th largest token spot. GNO's market cap stands at $303.88 million versus BONK's $330.07 million, requiring a price rise to about $125.48 for t...
Broadridge's Tokenization Pulse Survey shows 84% of firms view tokenization as strategically important, with 68% expecting it to reshape markets within 3-5 years. Most firms plan to integrate tokenization into existing infrastructure rather than buil...
Standard Chartered has partnered with Broadcom to modernize its global banking infrastructure by adopting a secure, resilient private cloud using VMware Cloud Foundation. This upgrade supports critical banking services across 54 markets with enhanced...
